(S)-5-fluoro-3-methylisobenzofuran-1(3H)-one

Acute Toxicity: oral

Administrative data

Endpoint:

acute toxicity: oral

Type of information:

experimental study

Adequacy of study:

key study

Study period:

From 16 Feb to 08 Mar 2016

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

2016

Report date:

2016

Materials and methods

Test guideline

Qualifier:

according to guideline

Guideline:

OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)

Deviations:

no

GLP compliance:

yes

Test type:

acute toxic class method

Limit test:

yes

Test material

Test material information

Constituent 1

Reference substance name:

(3S)-5-fluoro-3-methyl-1,3-dihydro-2-benzofuran-1-one

EC Number:

943-180-4

Cas Number:

1803573-19-4

Molecular formula:

C9H7FO2

IUPAC Name:

(3S)-5-fluoro-3-methyl-1,3-dihydro-2-benzofuran-1-one

Test material form:

solid: particulate/powder

Remarks:

migrated information: powder

Specific details on test material used for the study:

Batch No.: E010016692Purity: 99.3%

Test animals

Species:

rat

Strain:

Wistar

Sex:

female

Details on test animals or test system and environmental conditions:

TEST ANIMALS- Source: Charles River Deutschland, Sulzfeld, Germany- Age at study initiation: Young adult animals (approx. 8-9 weeks old)- Weight at study initiation: Body weight variation did not exceed +/- 20% of the sex mean- Fasting period before study: Animals were deprived of food overnight prior to dosing and until 3-4 hours after administration of the test item. Water was available ad libitum.- Housing: Group housing of 3 animals per cage in labeled Makrolon cages containing sterilized sawdust as bedding material and paper as cage-enrichment.- Diet (e.g. ad libitum): Free access to pelleted rodent diet- Water (e.g. ad libitum): Free access to tap water.- Acclimation period: At least 5 days before start of treatment under laboratory conditionsENVIRONMENTAL CONDITIONS- Temperature (°C): 18 to 24- Humidity (%): 40 to 70- Air changes (per hr): at least 10 air changes/hour- Photoperiod (hrs dark / hrs light): 12-hour light/12-hour dark cycle

Administration / exposure

Route of administration:

oral: gavage

Vehicle:

propylene glycol

Details on oral exposure:

VEHICLE- Concentration in vehicle: 200 mg/mL- Justification for choice of vehicle: The vehicle was selected based on trial preparations performed at WIL Research Europe and on test item data supplied by the Sponsor. There was no information available regarding the solubility or stability in vehicle.MAXIMUM DOSE VOLUME APPLIED: 2000 mg/kg (10 mL/kg) body weightCLASS METHOD (if applicable)- Rationale for the selection of the starting dose: The toxicity of the test item was assessed by stepwise treatment of groups of 3 females. The first group was treated at a dose level of 2000 mg/kg. The absence or presence of mortality of animals dosed at one step determined the next step, based on the test procedure defined in the guidelines. The onset, duration and severity of the signs of toxicity were taken into account for determination of the time interval between the dose groups.

Doses:

2000 mg/kg

No. of animals per sex per dose:

3 females at a dose level of 2000 mg/kg

Control animals:

no

Details on study design:

- Duration of observation period following administration: 14 days- Frequency of observations and weighing: Mortality/Viability: Twice daily. Body weights: Days 1 (pre-administration), 8 and 15. Clinical signs: At periodic intervals on the day of dosing (Day 1) and once daily thereafter, until Day 15.- Necropsy of survivors performed: yes, at the end of observation period, all animals were sacrificed by oxygen/carbon dioxide procedure and subjected to necropsy.- Other examinations performed: no.

Statistics:

None stated

Results and discussion

Effect levels

Sex:

female

Dose descriptor:

LD50

Effect level:

> 2 000 mg/kg bw

Based on:

test mat.

Mortality:

No mortality occurred.

Clinical signs:

other: Hunched posture, uncoordinated movements, quick breathing, rales, piloerection, salivation, watery discharge from the eye, ptosis and/or hypothermia were noted for the animals between Days 1 and 3.

Gross pathology:

No abnormalities were found at macroscopic post mortem examination of the animals.

Other findings:

No information provided.

Applicant's summary and conclusion

Interpretation of results:

not classified

Conclusions:

The oral LD50 value of test substance in Wistar rats was established to exceed 2000 mg/kg body weight.According to the OECD 423 test guideline, the LD50 cut-off value was considered to exceed 5000 mg/kg body weight.Based on these results:- according to the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) of the United Nations (2015) (including all amendments), the test substance should be classified as: may be harmful if swallowed (Category 5) for acute toxicity by the oral route;- according to the Regulation (EC) No 1272/2008 on classification, labelling and packaging of items and mixtures (including all amendments), the test substance does not have to be classified and has no obligatory labelling requirement for oral toxicity.